drugset / Trial / NCT02718859
Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer
Phase 1/2
Completed
60 enrolled
Fuda Cancer Hospital, Guangzhou
Shenzhen Hank Bioengineering Institute · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of the combined therapy using irreversible electroporation（IRE）and nature killer(NK) cells for advanced pancreatic cancer.
Timeline
- Start
- 2016-03-01
- Primary completion
- 2017-03-01
- Completion
- 2019-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TROCULEUCEL | Cell therapy | — | — |